US Patent Number
Butyrylcholinesterase (BChE) polypeptide variants of the presently-disclosed subject matter have enhanced catalytic efficiency for (−)-cocaine, as compared to wild-type BChE. Pharmaceutical compositions of the presently-disclosed subject matter include a BChE polypeptide variant having an enhanced catalytic efficiency for (−)-cocaine. A method of the presently-disclosed subject matter for treating a cocaine-induced condition includes administering to an individual an effective amount of a BChE polypeptide variant, as disclosed herein, to lower blood cocaine concentration.
University of Kentucky Research Foundation, Lexington, KY (US)
Zhan, Chang-Guo; Zheng, Fang; Yang, Wenchao; Xue, Lin; and Hou, Shurong, "High Activity Mutants of Butyrylcholinesterase for Cocaine Hydrolysis" (2015). Pharmaceutical Sciences Faculty Patents. 26.